Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-β-cyclodextrin in rabbit

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 9, 2010, Pages 1574-1578

  Ito, Yoshimasa ^a   Nagai, Noriaki ^a   Shimomura, Yoshikazu ^b  

^a KINKI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 hydroxypropyl cyclodextrin; Disulfiram; Glaucoma; Hydroxypropylmethylcellulose; Nitric oxide

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DIETHYLTHIOCARBAMATE; DISULFIRAM; EYE DROPS; GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; OCULOPLETHYSMOGRAPHY; OXIDATIVE STRESS; RABBIT;

ANIMALS; AQUEOUS HUMOR; BETA-CYCLODEXTRINS; DISULFIRAM; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; RABBITS;

EID: 77957587464     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1574     Document Type: Article

References (32)

1. Armaly M. F., Krueger D. E., Maunder L., Becker B., Hetherington J. Jr., Kolker A. E., Levene R. Z., Maumenee A. E., Pollack I. P., Shaffer R. N., Arch. Ophthalmol., 98, 2163-2171 (1980).
2. Quigley H. A., Addicks E. M., Green W. R., Maumenee A. E., Arch. Ophthalmol., 99, 635-649 (1981).
3. Quigley H. A., Br. J. Ophthalmol., 80, 389-393 (1996).
4. Guo L., Moss S. E., Alexander R. A., Ali R. R., Fitzke F. W., Cordeiro M. F., Invest. Ophthalmol. Vis. Sci., 46, 175-182 (2005).
5. Osborne N. N., Barnett N. L., Herrera A. J., Brain Res., 610, 194-198 (1993).
6. Nathanson J. A., McKee M., Ophthalmol. Vis. Sci., 36, 1765-1773 (1995).
7. Meyer P., Champion C., Schlotzer S. U., Flammer J., Haefliger I. O., Curr. Eye Res., 18, 375-380 (1999).
8. Wiederholt M., Sturm A., Lepple W. A., Invest. Ophthalmol. Vis. Sci., 35, 2515-2520 (1994).
9. Goh Y., Hotehama Y., Mishima H. K., Invest. Ophthalmol. Vis. Sci., 36, 1188-1192 (1995).
10. Kiel J. W., Reitsamer H. A., Walker J. S., Kiel F. W., Exp. Eye Res., 73, 355-364 (2001).
11. Mulsch A., Schray-Utz B., Mordvintcev P. I., Hauschildt S., Busse R., FEBS Lett., 321, 215-218 (1993).
12. Schreck R., Meier B., Mannel D. N., Droge W., Baeuerle P. A., J. Exp. Med., 175, 1181-1194 (1992).
13. Ito Y., Cai H., Koizumi Y., Hori R., Terao M., Kimura T., Takagi S., Tomohiro M., Biol. Pharm. Bull., 23, 327-333 (2000).
14. Rall T. W., "The Pharmacological Basis of Therapeutics," 8th ed., ed. by Gilman A. G., Rall T. W., Nies A. S., Taylor P., Perfamon Press, New York, 1990, pp. 378-379.
15. Irie T., Uekama K., J. Pharm. Sci., 86, 147-162 (1997).
16. Mueller B. W., Brauns U., Int. J. Pharm., 26, 77-88 (1985).
17. Kristinsson J. K., Fridriksdottir H., Thorisdottir S., Sigurdardottir A. M., Stefansson E., Loftsson T., Invest. Ophthalmol. Vis. Sci., 37, 1199-1203 (1996).
18. Wang S., Li D., Ito Y., Liu X., Zhang J., Wu C., J. Pharm. Pharmacol., 56, 1251-1257 (2004).
19. Nagai N., Takeda M., Ito Y., Takeuchi T., Kamei A., Biol. Pharm. Bull., 30, 1529-1534 (2007).
20. Iwata S., Osada Y., Ogino H., Yakugaku Zasshi, 100, 402-406 (1980).
21. Ito Y., Cai H., Koizumi Y., Nakao M., Terao M., Curr. Eye Res., 18, 292-299 (1999).
22. Meisner D., Pringle J., Mezei M., Int. J. Pharm., 55, 105-113 (1989).
23. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
24. Bonomi L., Tomazzoli L., Jaria D., Invest. Ophthalmol., 15, 781-784 (1976).
25. Saarinen S. P., Jarvinen T., Araki S. K., Watanabe H., Urtti A., Pharm. Res., 15, 1275-1280 (1998).
26. Jansen T., Xhonneux B., Mesens J., Borgers M., Lens Eye Toxic. Res., 7, 459-468 (1990).
27. King G., Holmes R., J. Exp. Zool., 282, 12-17 (1998).
28. Nagai N., Inomata M., Ito Y., Biol. Pharm. Bull., 31, 444-448 (2008).
29. Schultz G. S., Davis J. B., Eiferman R. A., Cornea, 7, 96-101 (1988).
30. Shah G. B., Sharma S., Mehta A. A., Goyal R. K., J. Cardiovasc. Pharmacol., 36, 169-175 (2000).
31. Kiel J. W., Exp. Eye Res., 69, 413-429 (1999).
32. Nagai N., Ito Y., Takeuchi N., Biol. Pharm. Bull., 31, 981-985 (2008).